128 related articles for article (PubMed ID: 11683788)
1. Hyperdiploid karyotype in a childhood MDS patient.
Acar H; Calişkan U U; Kaynak M; Yildirim MS; Largaespada DA
Clin Lab Haematol; 2001 Aug; 23(4):255-8. PubMed ID: 11683788
[TBL] [Abstract][Full Text] [Related]
2. Paediatric myelodysplastic syndrome (MDS) and juvenile chronic myelogenous leukaemia (JCML) detected by cytogenetic and FISH techniques.
Acar H; Caliskan U; Cora T
Clin Lab Haematol; 1999 Dec; 21(6):403-6. PubMed ID: 10671994
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
4. Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization.
Sessarego M; Fugazza G; Gobbi M; Bruzzone R; Bisio R; Ghio R; Patrone F
Cancer Genet Cytogenet; 1998 Oct; 106(2):110-5. PubMed ID: 9797774
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
7. Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS).
White AD; Culligan DJ; Hoy TG; Jacobs A
Br J Haematol; 1992 Aug; 81(4):499-502. PubMed ID: 1390235
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasias.
Verdorfer I; Brecevic L; Saul W; Schenker B; Kirsch M; Trautmann U; Helm G; Gramatzki M; Gebhart E
Cancer Genet Cytogenet; 2001 Jan; 124(1):1-6. PubMed ID: 11165314
[TBL] [Abstract][Full Text] [Related]
9. [Karyotype studies of patients with a myelodysplastic syndrome].
Salamanchuk ZIa; Masliak ZV; Lozyns'ka MR; Vyhovs'ka IaI; Lohins'kyĭ VIe; Male P
Tsitol Genet; 1998; 32(1):43-8. PubMed ID: 9695251
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of refractory anemia with excess blasts in transformation.
Ohyashiki K; Nishimaki J; Shoji N; Miyazawa K; Kimura Y; Ohyashiki JH
Leuk Res; 2001 Nov; 25(11):933-9. PubMed ID: 11597728
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
[TBL] [Abstract][Full Text] [Related]
12. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
14. Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.
Ketterling RP; Wyatt WA; VanWier SA; Law M; Hodnefield JM; Hanson CA; Dewald GW
Leuk Res; 2002 Mar; 26(3):235-40. PubMed ID: 11792411
[TBL] [Abstract][Full Text] [Related]
15. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
[TBL] [Abstract][Full Text] [Related]
16. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
[TBL] [Abstract][Full Text] [Related]
19. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
[TBL] [Abstract][Full Text] [Related]
20. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
Panani AD; Pappa V
In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
